PROGRAM

What to keep in mind

What you pay may also change over time. When you start treatment, costs will be based on receiving LEQEMBI infusions twice monthly (once every 2 weeks) or 2 once-weekly self-injections with LEQEMBI IQLIK. After 18 months of treatment, costs may change if you start maintenance treatment. You and your healthcare provider will determine if you can switch to less-frequent, once-monthly (once every 4 weeks) infusions, or once-weekly (once every 7 days) at-home injections with LEQEMBI IQLIK. LEQEMBI IQLIK is an injection given under the skin (a subcutaneous injection) by you or a care partner.

Please contact your care team or insurance provider, or use the LEQEMBI Companion Program to help you better understand your coverage and any out-of-pocket costs you may have.

How costs are calculated

The list (or wholesale) price for LEQEMBI intravenous (IV) infusions is $271.83 for a 200-mg vial and $679.60 for a 500-mg vial. Because LEQEMBI IV infusions has weight-based dosing, the price per patient is based on the number of medication vials needed. For example, based on the list price, treatment for a patient who weighs 165 pounds and receives LEQEMBI IV twice monthly (once every 2 weeks) would cost $28,270.32 per year.

The list price for LEQEMBI IQLIK injections is $770 for two 250-mg, single-dose, prefilled autoinjectors; and $385 for a 360-mg, single-dose, prefilled autoinjector. Because the starting dose of LEQEMBI IQLIK is 2 injections, administered once weekly for the first 18 months, treatment would cost $60,060 for the first 1 and a half years. After 18 months, if your HCP decides maintenance dosing is right for you, LEQEMBI IQLIK is 1 injection administered once weekly making treatment $20,020 per year.

The list price does not reflect what patients typically pay. Prices are current as of July 2026 and are subject to change. The list price does not include the cost of diagnostic or treatment-related tests, or costs involved with receiving each dose.

For Patients with Medicare Part D Plans

Beginning in 2026, if you have Medicare Part D coverage, your maximum
out-of-pocket costs for all your covered prescriptions, including LEQEMBI IQLIK, will be $2,100 per year. You may also choose a Medicare payment option that lets you divide those costs into monthly payments throughout the year, which may help make expenses more predictable and easier to manage. Once you reach $2,100 in out-of-pocket expenses, your covered prescription medications will cost $0 for the remainder of the year. The
out-of-pocket cost cap is updated annually.

Medicare Prescription Payment Plan

If you have a Medicare drug plan or a Medicare Advantage plan with drug coverage, you're eligible to opt in to the Medicare Prescription Payment Plan. The Medicare Prescription Payment Plan is a free budgeting tool for your prescriptions. It can help manage your prescription costs by spreading payments over the calendar year (January-December). Enrollment is flexible, allowing you to opt in at any time each year.

Visit medicare.gov/prescription-payment-plan for more information.

For patients with employer or private health insurance your out-of-pocket cost for medicines is determined by your insurance provider.